ELANTAS BECK INDIA LTD. Fair Value
ELANTAS · Chemicals · Current price ₹11,316
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹1,462 | 16% ROE fading to 13% over ~10 yrs, on ₹1272 book |
| Relative P/E | ₹9,720 | EPS × 52.1 peer-median P/E |
| Graham floor | ₹2,310 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | — | No analyst coverage |
Is ELANTAS BECK INDIA LTD. undervalued?
DocStoX estimates the fair value of ELANTAS BECK INDIA LTD. at ₹3,779 per share, versus the current market price of ₹11,316. That puts the stock about -66.6% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹1,462), Relative P/E (₹9,720), Graham floor (₹2,310). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹1,462 (bear) to ₹3,779 (base) to ₹9,720 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on ELANTAS BECK INDIA LTD.
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.